Literature DB >> 26165406

Long-term Remission in a Female With Multiple Relapsed Juvenile Granulosa Cell Tumor.

Martin Benesch1, Herwig Lackner, Alexander Pilhatsch, Barbara Gürtl-Lackner, Wolfgang Schwinger, Christian Urban.   

Abstract

A 4 ½-year-old female was diagnosed with ovarian juvenile granulosa cell tumor stage IA. After complete tumor resection she received 4 courses of chemotherapy due to unfavorable histopathologic features (high mitotic index, high microvessel density, blood vessel invasion). One year after diagnosis, she experienced paraaortic lymph node relapse treated with surgery, local radiotherapy, and conventional and high-dose chemotherapy. A second, paratracheal lymph node relapse 7 months later necessitated surgical removal and radiotherapy. Subsequently an adjuvant antiangiogenesis-based treatment including paclitaxel, bevacizumab, thalidomide, and pegylated interferon was initiated and continued for 2 years. The female is now in third complete remission 6 years after second relapse.

Entities:  

Mesh:

Year:  2015        PMID: 26165406     DOI: 10.1097/MPH.0000000000000387

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

Review 1.  Pediatric Gynecologic Cancers.

Authors:  Lauren Pommert; William Bradley
Journal:  Curr Oncol Rep       Date:  2017-07       Impact factor: 5.075

Review 2.  Oncological Prognosis and Fertility Outcomes of Different Surgical Extents for Malignant Ovarian Sex-Cord Stromal Tumors: A Narrative Review.

Authors:  Jiawei Li; Jun Li; Wei Jiang
Journal:  Cancer Manag Res       Date:  2022-02-18       Impact factor: 3.989

3.  Thalidomide and lenalidomide for recurrent ovarian cancer: A systematic review of the literature.

Authors:  Clemens B Tempfer; Beate Schultheis; Ziad Hilal; Askin Dogan; Günther A Rezniczek
Journal:  Oncol Lett       Date:  2017-07-15       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.